Dow Up0.48% Nasdaq Up0.43%

Synta Pharmaceuticals Corp. (SNTA)

-NGM
4.03 0.04(0.98%) Aug 19, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Net Income (22,286) (23,557) (24,162) (22,515)
Operating Activities, Cash Flows Provided By or Used In
Depreciation169  168  143  148  
Adjustments To Net Income1,513  2,586  1,540  1,683  
Changes In Accounts Receivables -   -   -   -  
Changes In Liabilities363  348  4,172  3,786  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(633)185  (383)310  
Total Cash Flow From Operating Activities (20,874) (20,270) (18,690) (16,588)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(25)(23)(82)(16)
Investments11,503  16,220  (15,068)8,509  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities 11,478   16,197   (15,150) 8,493  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock56,547  10,118  37,653  11  
Net Borrowings(2,374)(2,501)19,200  (222)
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 54,173   7,617   56,853   (211)
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents 44,777   3,544   23,013   (8,306)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.